Prostate cancer (CaP) is associated with considerably reduced overall survival with high
mortality rates due to the development of resistance to both standard and novel therapies …

Prostate cancer (PCa) is one of the most frequently diagnosed malignancy. Although there
have been many advances in PCa diagnosis and therapy, the concrete mechanism remains …

Urologic cancers, comprising prostate carcinoma (PCa), renal cell carcinoma (RCC), and
bladder carcinoma (BCa), were the commonly occurred carcinoma amid males. Long …

Abstract Information processing tools and bioinformatics software have significantly
advanced researchers' ability to process and analyze biological data. Molecular data from …

Prostate cancer is one of the most common malignancies in men. It is characterized by a
high molecular genomic heterogeneity and, thus, molecular subtypes, that, to date, have not …

Prostate cancer (PCa) is a common type of cancer worldwide. The incidence of PCa
increases with age and it is the most common malignant tumor in men. Tissue biopsy and …

Background: The lack of sensitive and specific biomarkers for prostate cancer (PCa) has led
to over-diagnosis and overtreatment with uncertain benefit. Therefore, biomarkers for early …

This study aimed to investigate the role of prostate cancer associated transcript 1 (PCAT1)
underlying the molecular mechanisms of prostate cancer. Using GSE29886 data set …

Purpose Prostate cancer (PCa) causes a common male urinary system malignant tumour,
and the molecular mechanisms of PCa are related to the abnormal regulation of various …

Aberrant expression of long non-coding RNAs (lncRNAs), caused by alterations in DNA
methylation, is a driving factor in several cancers. Interplay between lncRNAs' aberrant …